Tempus AI (NASDAQ:TEM) Shares Gap Down – Time to Sell?

Tempus AI, Inc. (NASDAQ:TEM) shares gapped down before the market opened on Tuesday . The stock had previously closed at $49.87, but opened at $47.79. Tempus AI shares last traded at $46.51, with a volume of 2,005,129 shares.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. William Blair reissued a “market perform” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Guggenheim reissued a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Morgan Stanley boosted their target price on Tempus AI from $50.00 to $60.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Bank of America upped their price target on Tempus AI from $54.00 to $60.00 and gave the company a “neutral” rating in a research report on Monday, March 3rd. Finally, TD Cowen restated a “buy” rating and set a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $61.18.

Tempus AI Stock Performance

The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The company has a 50-day simple moving average of $55.51 and a 200 day simple moving average of $51.60.

Insider Activity

In other Tempus AI news, CAO Ryan M. Bartolucci sold 13,770 shares of the company’s stock in a transaction on Friday, January 31st. The shares were sold at an average price of $60.00, for a total value of $826,200.00. Following the sale, the chief accounting officer now directly owns 57,237 shares of the company’s stock, valued at approximately $3,434,220. This represents a 19.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Eric P. Lefkofsky sold 187,655 shares of Tempus AI stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $37.54, for a total transaction of $7,044,568.70. Following the completion of the sale, the chief executive officer now directly owns 9,557,283 shares in the company, valued at $358,780,403.82. This represents a 1.93 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,749,469 shares of company stock worth $322,529,733.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Operose Advisors LLC purchased a new stake in Tempus AI during the 4th quarter valued at about $25,000. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI in the third quarter valued at $30,000. Farther Finance Advisors LLC acquired a new position in Tempus AI during the 4th quarter worth about $34,000. Prestige Wealth Management Group LLC boosted its holdings in Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after acquiring an additional 965 shares during the period. Finally, NewEdge Advisors LLC acquired a new position in shares of Tempus AI in the fourth quarter valued at approximately $49,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.